Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan.
Yih-Jyh LinChia-Ni LinTannaz SedghiSylvia H HsuCary P GrossJung-Der WangShi-Yi WangPublished in: PloS one (2020)
Differential stage at diagnosis and treatment were substantially associated with the survival difference, but approximately two-thirds of the difference remained unexplained. Identifying the main drivers of the difference could help improve HCC survival in the USA.